STOCKWATCH
·
Major Chemicals
AGM/EGMApr 30, 2026, 08:04 AM

BAK AGM Approves FY2025 Financials with R$9.88B Loss; Elects New Board

AI Summary

BRASKEM S.A. held its Annual General Meeting on April 29, 2026, where shareholders approved the financial statements for the fiscal year ended December 31, 2025, which reported a net loss of R$ 9.88 billion, increasing accumulated losses to R$ 23.90 billion. The meeting also saw the election of a new Board of Directors for a two-year term, with Magda Maria de Regina Chambriard appointed as Chairman and Héctor Núñez as Vice-Chairman. Additionally, new members for the Fiscal Council were elected.

Key Highlights

  • Shareholders approved financial statements for the fiscal year ended December 31, 2025.
  • Company incurred a net loss of R$ 9,879,465,238.91 for FY2025.
  • Accumulated losses updated to R$ 23,901,578,923.33.
  • Election of new Board of Directors for a unified two-year term ending December 31, 2027.
  • Magda Maria de Regina Chambriard elected as Chairman of the Board.
  • Héctor Núñez elected as Vice-Chairman of the Board.
  • Election of new Fiscal Council members for a term ending December 31, 2026.
  • Paulo Roberto Britto Guimarães, José Mauro Mettrau Carneiro da Cunha, and Gesner José de Oliveira Filho qualified as Independent Directors.
BAK
Major Chemicals
BRASKEM SA

Price Impact